The midterm elections are certain to have implications for Wall Street, regardless of how they shape the balance of power in Congress.

Continue Reading Below

That’s because in every scenario there could be winners and losers in key sectors of the market, including banking, pharmaceuticals, companies that would benefit from government infrastructure projects and those that rely on healthy consumer spending, analysts say.

The scenario deemed most likely by recent polls and analyst projections has Democrats regaining control of the House of Representatives and Republicans keeping control of the Senate. The odds are longer for Republicans or Democrats emerging with majorities in both chambers.

“Divided government equals gridlock,” said Terry Haines, head of US policy and political analysis at Evercore ISI. “Gridlock is a good thing for markets because markets like certainty” a view echoed by Anthony Scaramucci, former White House Communications Director, during an appearance on FOX Business Network.

Here’s a look at how the market might react to the different scenarios compiled by The Associated Press and FOX Business.

SPLIT DECISION

In the scenario where Democrats regain control of the House, major policy initiatives from the White House will be dead on arrival. Compromise could be difficult, especially if the Democrats move to impeach President Donald Trump.

A divided Congress would mean increased equity volatility and an uncertain future for infrastructure spending while pharmaceutical stocks could benefit, according to the team at Goldman Sachs.

Legislators from both sides of the aisle have expressed an interest in infrastructure spending, and while analysts have voiced optimism over an infrastructure bill being passed next year, Goldman’s economists disagree. They assign a mere 25 percent likelihood that infrastructure spending legislation will be enacted if Republicans maintain control of Congress. If Democrats take control of one or both chambers, then an infrastructure bill is even less likely.

Midterms & Your Money